Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

BUY
$306.88 - $380.0 $6,444 - $7,980
21 Added 0.24%
8,673 $3.28 Million
Q3 2023

Oct 19, 2023

BUY
$315.92 - $397.36 $883,944 - $1.11 Million
2,798 Added 47.8%
8,652 $2.75 Million
Q2 2023

Jul 11, 2023

BUY
$346.15 - $392.09 $13,846 - $15,683
40 Added 0.69%
5,854 $2.24 Million
Q1 2023

Apr 17, 2023

BUY
$323.56 - $373.36 $13,913 - $16,054
43 Added 0.75%
5,814 $2.17 Million
Q4 2022

Jan 18, 2023

BUY
$248.67 - $334.17 $9,200 - $12,364
37 Added 0.65%
5,771 $0
Q3 2022

Oct 31, 2022

BUY
$263.81 - $337.27 $1.51 Million - $1.93 Million
5,734 New
5,734 $1.51 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Czech National Bank Portfolio

Follow Czech National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Czech National Bank with notifications on news.